{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:16:08Z","timestamp":1791832568416,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["2014\/14\/E\/NZ5\/00175"],"award-info":[{"award-number":["2014\/14\/E\/NZ5\/00175"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GZO\u2014Zurich Regional Health Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Angiotensin (Ang) II signalling has been suggested to promote cardiac fibrosis in inflammatory heart diseases; however, the underlying mechanisms remain obscure. Using Agtr1a-\/- mice with genetic deletion of angiotensin receptor type 1 (ATR1) and the experimental autoimmune myocarditis (EAM) model, we aimed to elucidate the role of Ang II-ATR1 pathway in development of heart-specific autoimmunity and post-inflammatory fibrosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>EAM was induced in wild-type (WT) and Agtr1a-\/- mice by subcutaneous injections with alpha myosin heavy chain peptide emulsified in complete Freund\u2019s adjuvant. Agtr1a-\/- mice developed myocarditis to a similar extent as WT controls at day 21 but showed reduced fibrosis and better systolic function at day 40. Crisscross bone marrow chimaera experiments\u00a0proved that ATR1 signalling in the bone marrow compartment was critical for cardiac fibrosis. Heart infiltrating, bone-marrow-derived cells produced Ang II, but lack of ATR1 in these cells reduced transforming growth factor beta (TGF-\u03b2)-mediated fibrotic responses. At the molecular level, Agtr1a-\/- heart-inflammatory\u00a0cells showed impaired TGF-\u03b2-mediated phosphorylation of Smad2 and TAK1. In WT cells, TGF-\u03b2 induced formation of RhoA-GTP and RhoA-A-kinase anchoring protein-Lbc (AKAP-Lbc) complex. In Agtr1a-\/- cells, stabilization of RhoA-GTP and interaction of RhoA with AKAP-Lbc were largely impaired. Furthermore, in contrast to WT cells, Agtr1a-\/- cells stimulated with TGF-\u03b2 failed to activate canonical Wnt pathway indicated by suppressed activity of glycogen synthase kinase-3 (GSK-3)\u03b2 and nuclear \u03b2-catenin translocation and showed reduced expression of Wnts. In line with these in vitro findings, \u03b2-catenin was detected in inflammatory regions of hearts of WT, but not Agtr1a-\/- mice and expression of canonical Wnt1 and Wnt10b were lower in Agtr1a-\/- hearts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Ang II-ATR1 signalling is critical for development of post-inflammatory fibrotic remodelling and dilated cardiomyopathy. Our data underpin the importance of Ang II-ATR1 in effective TGF-\u03b2 downstream signalling response including activation of profibrotic Wnt\/\u03b2-catenin pathway.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cvr\/cvab039","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T14:19:56Z","timestamp":1612534796000},"page":"573-584","source":"Crossref","is-referenced-by-count":35,"title":["Angiotensin II receptor 1 controls profibrotic Wnt\/\u03b2-catenin signalling in experimental autoimmune myocarditis"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4402-1738","authenticated-orcid":false,"given":"Marcin","family":"Czepiel","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, Jagiellonian University Medical College, Wielicka 265, 30-663, Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4375-3718","authenticated-orcid":false,"given":"Dario","family":"Diviani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Lausanne, Rue du Bugnon 7, 1005, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9107-4395","authenticated-orcid":false,"given":"Agnieszka","family":"Ja\u017awa-Kusior","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-9126","authenticated-orcid":false,"given":"Karolina","family":"Tkacz","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Jagiellonian University Medical College, Wielicka 265, 30-663, Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-6169","authenticated-orcid":false,"given":"Filip","family":"Rolski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Jagiellonian University Medical College, Wielicka 265, 30-663, Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-9414","authenticated-orcid":false,"given":"Ryszard T","family":"Smolenski","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, M. Sk\u0142odowskiej-Curie 3a, 80-210, Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3904-5412","authenticated-orcid":false,"given":"Maciej","family":"Siedlar","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Jagiellonian University Medical College, Wielicka 265, 30-663, Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-9696","authenticated-orcid":false,"given":"Urs","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Cardioimmunology, Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland, GZO\u2014Zurich Regional Health Center, Spitalstrasse 66, 8620, Wetzikon, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3788-4594","authenticated-orcid":false,"given":"Gabriela","family":"Kania","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-3232","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"B\u0142yszczuk","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Jagiellonian University Medical College, Wielicka 265, 30-663, Cracow, Poland"},{"name":"Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"2022013117294705300_cvab039-B1","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.jacc.2016.09.937","article-title":"The quest for new approaches in myocarditis and inflammatory cardiomyopathy","volume":"68","author":"Heymans","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2022013117294705300_cvab039-B2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"The Lancet"},{"key":"2022013117294705300_cvab039-B3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2022013117294705300_cvab039-B4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fcvm.2019.00064","article-title":"Myocarditis in humans and in experimental animal models","volume":"6","author":"B\u0142yszczuk","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2022013117294705300_cvab039-B5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/cvr\/cvs317","article-title":"Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133+ progenitors into F4\/80+ macrophages in experimental autoimmune myocarditis","volume":"97","author":"Blyszczuk","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2022013117294705300_cvab039-B6","first-page":"1413","article-title":"Transforming growth factor-\u03b2-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis","volume":"38","author":"Blyszczuk","year":"2017","journal-title":"Eur Heart J"},{"key":"2022013117294705300_cvab039-B7","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin-angiotensin-aldosterone system and its therapeutic targets","volume":"186","author":"Mirabito Colafella","year":"2019","journal-title":"Exp Eye Res Elsevier"},{"key":"2022013117294705300_cvab039-B8","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.92.8.3521","article-title":"Regulation of blood pressure by the type 1A angiotensin II receptor gene","volume":"92","author":"Ito","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"2022013117294705300_cvab039-B9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.2009.134","article-title":"AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla","volume":"76","author":"Li","year":"2009","journal-title":"Kidney Int"},{"key":"2022013117294705300_cvab039-B10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00395-019-0722-5","article-title":"Inflammation and fibrosis in murine models of heart failure","volume":"114","author":"Bacmeister","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"2022013117294705300_cvab039-B11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol Res"},{"key":"2022013117294705300_cvab039-B12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbamcr.2013.11.008","article-title":"A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts","volume":"1843","author":"Cavin","year":"2014","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2022013117294705300_cvab039-B13","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1073\/pnas.0701099104","article-title":"The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates \u03b11 adrenergic receptor-induced cardiomyocyte hypertrophy","volume":"104","author":"Appert-Collin","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022013117294705300_cvab039-B14","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0022-2828(95)91983-X","article-title":"Angiotensin II stimulates the autocrine production of transforming growth factor-\u03b21 in adult rat cardiac fibroblasts","volume":"27","author":"Lee","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"2022013117294705300_cvab039-B15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.HYP.32.2.273","article-title":"Early induction of transforming growth factor-\u03b2 via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats","volume":"32","author":"Tomita","year":"1998","journal-title":"Hypertension"},{"key":"2022013117294705300_cvab039-B16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-\u03b21 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J Clin Invest"},{"key":"2022013117294705300_cvab039-B17","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1038\/s41598-018-27064-2","article-title":"An essential role for Wnt\/\u03b2-catenin signaling in mediating hypertensive heart disease","volume":"8","author":"Zhao","year":"2018","journal-title":"Sci Rep"},{"key":"2022013117294705300_cvab039-B18","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/jcp.25275","article-title":"Thymosin \u03b24 prevents angiotensin II-induced cardiomyocyte growth by regulating Wnt\/WISP signaling","volume":"231","author":"Li","year":"2016","journal-title":"J Cell Physiol"},{"key":"2022013117294705300_cvab039-B19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2010.10.081","article-title":"Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress","volume":"652","author":"Sukumaran","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2022013117294705300_cvab039-B20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:MCBI.0000021379.82282.53","article-title":"Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 agonist, upon acute autoimmune myocarditis","volume":"259","author":"Nimata","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"2022013117294705300_cvab039-B21","doi-asserted-by":"crossref","first-page":"H1147","DOI":"10.1152\/ajpheart.00078.2005","article-title":"Olmesartan, a novel AT 1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure","volume":"289","author":"Yuan","year":"2005","journal-title":"Am J Physiol Circ Physiol"},{"key":"2022013117294705300_cvab039-B22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7150\/ijbs.7.154","article-title":"Olmesartan, an AT 1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis","volume":"7","author":"Sukumaran","year":"2011","journal-title":"Int J Biol Sci"},{"key":"2022013117294705300_cvab039-B23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/1348-0421.12548","article-title":"Angiotensin II-C-C chemokine receptor2\/5 axis-dependent monocyte\/macrophage recruitment contributes to progression of experimental autoimmune myocarditis","volume":"61","author":"Lu","year":"2017","journal-title":"Microbiol Immunol"},{"key":"2022013117294705300_cvab039-B24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/JLB.3A0617-264RR","article-title":"ANG II facilitated CD11 + Ly6C hi cells reprogramming into M1-like macrophage through Erk1\/2 or p38-Stat3 pathway and involved in EAM","volume":"103","author":"Lu","year":"2018","journal-title":"J Leukoc Biol"},{"key":"2022013117294705300_cvab039-B25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2007.04.062","article-title":"Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis","volume":"125","author":"Bahk","year":"2008","journal-title":"Int J Cardiol"},{"key":"2022013117294705300_cvab039-B26","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.7150\/ijbs.7.1077","article-title":"Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2\/angiotensin 1-7\/mas receptor axis","volume":"7","author":"Sukumaran","year":"2011","journal-title":"Int J Biol Sci"},{"key":"2022013117294705300_cvab039-B27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2011.12.010","article-title":"Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1\u20137 mas receptor","volume":"351","author":"Sukumaran","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2022013117294705300_cvab039-B28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.lfs.2011.11.018","article-title":"Telmisartan acts through the modulation of ACE-2\/ANG 1\u20137\/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis","volume":"90","author":"Sukumaran","year":"2012","journal-title":"Life Sci"},{"key":"2022013117294705300_cvab039-B29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/hr.2010.67","article-title":"Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy","volume":"33","author":"Sukumaran","year":"2010","journal-title":"Hypertens Res"},{"key":"2022013117294705300_cvab039-B30","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1258\/ebm.2010.010016","article-title":"Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy","volume":"235","author":"Sukumaran","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"2022013117294705300_cvab039-B31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin ii receptor antagonist with selective PPAR\u03b3\u2013modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"2022013117294705300_cvab039-B32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.07.014","article-title":"Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor \u03b3","volume":"72","author":"Imayama","year":"2006","journal-title":"Cardiovasc Res"},{"key":"2022013117294705300_cvab039-B33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/labinvest.2011.45","article-title":"Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma","volume":"91","author":"Maejima","year":"2011","journal-title":"Lab Invest"},{"key":"2022013117294705300_cvab039-B34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-017-0128-7","article-title":"Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects","volume":"18","author":"Chartier","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"2022013117294705300_cvab039-B35","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.112.000434","article-title":"Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis","volume":"127","author":"Kania","year":"2013","journal-title":"Circulation"},{"key":"2022013117294705300_cvab039-B36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00395-019-0766-6","article-title":"Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis","volume":"115","author":"Zarak-Crnkovic","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"2022013117294705300_cvab039-B37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-4939-7030-8_14","article-title":"A primer to angiotensin peptide isolation, stability, and analysis by nano-liquid chromatography with mass detection","volume":"1614","author":"Olkowicz","year":"2017","journal-title":"Methods Mol Biol"},{"key":"2022013117294705300_cvab039-B38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-59745-249-6_4","article-title":"Measuring GSK3 expression and activity in cells","volume":"468","author":"Cole","year":"2008","journal-title":"Methods Mol Biol"},{"key":"2022013117294705300_cvab039-B39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.18388\/abp.2018_2635","article-title":"Crosstalk between the TGF-\u03b2 and WNT signalling pathways during cardiac fibrogenesis","volume":"65","author":"Dzia\u0142o","year":"2018","journal-title":"Acta Biochim Pol"},{"key":"2022013117294705300_cvab039-B40","first-page":"59","article-title":"Signaling in fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ converge","volume":"2","author":"Piersma","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"2022013117294705300_cvab039-B41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccl.2013.09.002","article-title":"The renin-angiotensin-aldosterone system and heart failure","volume":"32","author":"Sayer","year":"2014","journal-title":"Cardiol Clin"},{"key":"2022013117294705300_cvab039-B42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/01.HYP.0000196946.79674.8b","article-title":"Regulation of peroxisome proliferator\u2013activated receptor \u03b3 activity by losartan metabolites","volume":"47","author":"Schupp","year":"2006","journal-title":"Hypertension"},{"key":"2022013117294705300_cvab039-B43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1159\/000369747","article-title":"Activation of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) through NF-\u03baB\/brg1 and TGF-\u03b2 1 pathways attenuates cardiac remodeling in pressure-overloaded rat hearts","volume":"35","author":"Qi","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"2022013117294705300_cvab039-B44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40520-015-0408-2","article-title":"Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts","volume":"28","author":"Xie","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"2022013117294705300_cvab039-B45","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/HYPERTENSIONAHA.114.05065","article-title":"Angiotensin II activates the RhoA exchange factor Arhgef1 in humans","volume":"65","author":"Carbone","year":"2015","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"2022013117294705300_cvab039-B46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/cells9030700","article-title":"Haploinsufficient Rock1+\/\u2212 and Rock2+\/\u2212 mice are not protected from cardiac inflammation and postinflammatory fibrosis in experimental autoimmune myocarditis","volume":"9","author":"Tkacz","year":"2020","journal-title":"Cells"},{"key":"2022013117294705300_cvab039-B47","doi-asserted-by":"crossref","first-page":"60640","DOI":"10.18632\/oncotarget.17457","article-title":"Wnt\/\u03b2-catenin pathway in arrhythmogenic cardiomyopathy","volume":"8","author":"Lorenzon","year":"2017","journal-title":"Oncotarget"},{"key":"2022013117294705300_cvab039-B48","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/art.34424","article-title":"Wnt\/\u03b2-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells","volume":"64","author":"Wei","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022013117294705300_cvab039-B49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gene.2018.06.053","article-title":"Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis","volume":"674","author":"Wang","year":"2018","journal-title":"Gene"},{"key":"2022013117294705300_cvab039-B50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/hr.2011.196","article-title":"Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2\/3-independent","volume":"35","author":"Watkins","year":"2012","journal-title":"Hypertens Res"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvab039\/36599617\/cvab039.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/2\/573\/42341002\/cvab039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/2\/573\/42341002\/cvab039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T17:50:49Z","timestamp":1643651449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/118\/2\/573\/6134076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,8]]},"published-print":{"date-parts":[[2022,1,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvab039","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,2,8]]}}}